Rob Woods Selected Research

Rob Woods Research Topics

6	Neoplasms (Cancer) 01/2016 - 06/2009
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 10/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2021
1	Out-of-Hospital Cardiac Arrest 09/2020
1	Clostridium Infections 01/2018
1	Inflammation (Inflammations) 01/2018
1	Diarrhea 01/2018
1	Sepsis (Septicemia) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Reperfusion Injury 01/2018
1	Infections 01/2018
1	Reinfection 01/2017
1	Asthma (Bronchial Asthma) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 09/2015
1	Body Weight (Weight, Body) 05/2012

5	Monoclonal AntibodiesIBA 01/2017 - 06/2009
3	AntibodiesIBA 01/2016 - 06/2009
2	interleukin-21 (interleukin 21)IBA 01/2019 - 01/2018
2	MEDI3617IBA 03/2013 - 05/2012
2	Angiopoietin-2IBA 03/2013 - 05/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	AnaphylatoxinsIBA 01/2018
1	Anaphylatoxin C5a ReceptorIBA 01/2018
1	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2018
1	DisulfidesIBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Sulfhydryl Compounds (Thiols)IBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Erythropoietin FDA Link 09/2015
1	AntigensIBA 09/2015
1	Bevacizumab (Avastin)FDA Link 05/2012
1	Angiogenesis InhibitorsIBA 05/2012
1	TIE-2 Receptor (Receptor, TIE 2)IBA 05/2012
1	Retinaldehyde (Retinal)IBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 05/2012
1	inebilizumabIBA 10/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2009

1	Resuscitation 06/2021
1	Cardiopulmonary Resuscitation (CPR) 09/2020
1	Therapeutics 09/2015
1	Drug Therapy (Chemotherapy) 05/2012